Swedish Orphan Fair Value
B6
The fair market value of B6E.DU stock is 21.08 EUR. Relative to the market price of 27.86 EUR Swedish Orphan is overvalued by 24.3%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Swedish Orphan Valuation
Current B6E.DU share ticker price is 27.86 EUR.
The fair value level of 21.08 EUR can be considered as an effective entry point for long-term investors to start investing in B6E.DU stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 24% higher its fair value
Current price is 52% higher its minimum value
Current price is 11% lower its maximum value
Market price:
B6E.DU stock is overvalued
It means the current price may concern as a Risky Entry Point
Swedish Orphan Biovitrum AB (publ) Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
35.42
2
Median P/E over 5 years
24.2
3
Minimum P/E over 5 years
15.46
4
Earning per share (last 12 months)
10.08 SEK
Maximum value
1
x
4
=
30.86 EUR
Fair value
2
x
4
=
21.08 EUR
Minimum value
3
x
4
=
13.47 EUR
Swedish Orphan Biovitrum AB (publ) price metrics
15.82
Annual return (geometric mean)
36.48
Risk (standard deviation) of returns
β
1.14
Beta (volatility compared to market)